story of the week
SLGT2 Inhibitors vs Sulfonylureas in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Internal Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes
JAMA Intern Med 2021 Jun 28;[EPub Ahead of Print], Y Xie, B Bowe, AK Gibson, JB McGill, G Maddukuri, Z Al-AlyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.